Enanta Pharmaceuticals, Inc. Share Price
ENTAEnanta Pharmaceuticals, Inc. Stock Performance
Open $13.98 | Prev. Close $13.83 | Circuit Range N/A |
Day Range $13.98 - $14.19 | Year Range $5.55 - $17.11 | Volume 2,205 |
Average Traded $14.12 |
Enanta Pharmaceuticals, Inc. Share Price Chart
About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Enanta Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $13.90 | $13.64 | -0.91% |
19-May-26 | $13.38 | $13.77 | +2.38% |
18-May-26 | $13.47 | $13.45 | -0.11% |
15-May-26 | $13.67 | $13.46 | -2.04% |
14-May-26 | $13.76 | $13.74 | -2.59% |
13-May-26 | $14.72 | $14.11 | -2.76% |
12-May-26 | $14.60 | $14.51 | -6.36% |
FAQs on Enanta Pharmaceuticals, Inc. Share Price
Can I buy Enanta Pharmaceuticals, Inc. shares in India?
What is the share price of Enanta Pharmaceuticals, Inc.?
What is the 5 year returns of Enanta Pharmaceuticals, Inc.?
What are the high & low stock price of Enanta Pharmaceuticals, Inc. today?
What is the 52-week high and low of Enanta Pharmaceuticals, Inc. stock?